The SURMOUNT-1 Phase 3 trial published in the New England Journal of Medicine demonstrated 20.9% mean body weight reduction at 72 weeks on tirzepatide 15mg weekly versus 3.1% with placebo
BPC-157 With Growth Hormone Support Peptides Combining BPC-157 with growth-hormone secretagogues enhances overall recovery, improves sleep, and supports lean tissue repair
Before receiving an injection, a person should speak with their doctor to check if any of the ingredients may be harmful when combined with existing medications or medical conditions a person has
Who Is This Injection For
Avoid Environmental Toxins Limit exposure to plastic, synthetic candles, harsh cleaning products, and chemicals in cosmetics
The key principle is that tirzepatide is more potent on a milligram basis than semaglutide, so direct milligram equivalents do not apply